Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nutrients ; 16(8)2024 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-38674881

RESUMO

Anorexia nervosa (AN) induces organ dysfunction caused by malnutrition, including liver damage leading to a rise in transaminases due to hepatocyte damage. The underlying pathophysiology of starvation-induced liver damage is poorly understood. We investigate the effect of a 25% body weight reduction on murine livers in a mouse model and examine possible underlying mechanisms of starvation-induced liver damage. Female mice received a restricted amount of food with access to running wheels until a 25% weight reduction was achieved. This weight reduction was maintained for two weeks to mimic chronic starvation. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured spectrophotometrically. Liver fat content was analyzed using an Oil Red O stain, and liver glycogen was determined using a Periodic acid-Schiff (PAS) stain. Immunohistochemical stains were used to investigate macrophages, proliferation, apoptosis, and autophagy. Starvation led to an elevation of AST and ALT values, a decreased amount of liver fat, and reduced glycogen deposits. The density of F4/80+ macrophage numbers as well as proliferating KI67+ cells were decreased by starvation, while apoptosis was not altered. This was paralleled by an increase in autophagy-related protein staining. Increased transaminase values suggest the presence of liver damage in the examined livers of starved mice. The observed starvation-induced liver damage may be attributed to increased autophagy. Whether other mechanisms play an additional role in starvation-induced liver damage remains to be investigated.


Assuntos
Alanina Transaminase , Aspartato Aminotransferases , Autofagia , Fígado , Inanição , Animais , Feminino , Fígado/metabolismo , Fígado/patologia , Camundongos , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Hepatopatias/etiologia , Hepatopatias/patologia , Modelos Animais de Doenças , Apoptose , Macrófagos/metabolismo , Camundongos Endogâmicos C57BL , Glicogênio Hepático/metabolismo
2.
Cells ; 9(10)2020 09 25.
Artigo em Inglês | MEDLINE | ID: mdl-32992982

RESUMO

Epac1 (exchange protein activated by cAMP) stabilizes the endothelial barrier, but detailed studies are limited by the side effects of pharmacological Epac1 modulators and transient transfections. Here, we compare the key properties of barriers between endothelial cells derived from wild-type (WT) and Epac1-knockout (KO) mice myocardium. We found that KO cell layers, unlike WT layers, had low and cAMP-insensitive trans-endothelial resistance (TER). They also had fragmented VE-cadherin staining despite having augmented cAMP levels and increased protein expression of Rap1, Rac1, RhoA, and VE-cadherin. The simultaneous direct activation of Rac1 and RhoA by CN04 compensated Epac1 loss, since TER was increased. In KO-cells, inhibition of Rac1 activity had no additional effect on TER, suggesting that other mechanisms compensate the inhibition of the Rac1 function to preserve barrier properties. In summary, Epac1 is crucial for baseline and cAMP-mediated barrier stabilization through mechanisms that are at least partially independent of Rac1.


Assuntos
Células Endoteliais/metabolismo , Fatores de Troca do Nucleotídeo Guanina/genética , Miocárdio/metabolismo , Neuropeptídeos/genética , Proteínas rac1 de Ligação ao GTP/genética , Proteínas rap1 de Ligação ao GTP/efeitos dos fármacos , Animais , Antígenos CD/genética , Caderinas/genética , Permeabilidade da Membrana Celular/efeitos dos fármacos , AMP Cíclico/genética , Células Endoteliais/patologia , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Camundongos , Camundongos Knockout , Miocárdio/patologia , Neuropeptídeos/agonistas , Transdução de Sinais/genética , Ativação Transcricional/efeitos dos fármacos , Proteínas rac1 de Ligação ao GTP/agonistas , Proteína rhoA de Ligação ao GTP/agonistas , Proteína rhoA de Ligação ao GTP/genética
3.
Shock ; 28(5): 564-9, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17589384

RESUMO

One of the clinical characteristics associated with septic shock is heart failure. Several lines of evidence indicate that functional consequences of heart failure in septic shock are linked to the activated NO-cyclic guanosine monophosphate (NO-cGMP) pathway. We have previously shown that the high-affinity cGMP export transporter, multidrug resistance protein 5 (MRP5), is expressed in the heart, which modulates intracellular concentrations and, hence, the effects of cGMP. Thus, modified expression of cardiac MRP5 in septic shock can alter cGMP concentrations and contribute to the development of heart failure. We therefore investigated MRP5 expression in the heart using two established murine models of septic shock (intraperitoneal LPS injection and surgical implantation of a stent into the ascending colon, resulting in a multibacterial peritonitis [CASP, colon ascendens stent peritonitis] in C57BL/6N mice, respectively; n = 38). Cardiac MRP5 was assessed by quantitative polymerase chain reaction and immunofluorescence. The protein was localized in the endothelial wall, smooth muscle, and cardiac myocytes. MRP5 mRNA expression was significantly reduced compared with controls both in the LPS (31.9 +/- 16.8 x 10(-4) vs. 54.1 +/- 14.8 x 10(-4), P = 0.025) and CASP model (18.3 +/- 9.4 x 10(-4) vs. 42.8 +/- 12.1 x 10(-4), P = 0.009; MRP5/glyceraldehyde 3-phosphate dehydrogenase copy numbers, respectively). In parallel, IL-6 plasma levels were significantly increased in both models. Incubation of cultured murine cardiomyocytes (HL1) with 5 ng/mL IL-6 resulted in decreased expression of MRP5 (54% of control), as did incubation of the cells with serum from septic mice (LPS serum, 22% of control; CASP serum, 11% of control). In conclusion, cardiac expression of the cGMP export transporter MRP5 is decreased in two murine models of septic shock, most likely by a transcriptional mechanism. Reduced cGMP export as a consequence of decreased MRP5 expression can attenuate heart failure in sepsis.


Assuntos
GMP Cíclico/metabolismo , Regulação da Expressão Gênica , Insuficiência Cardíaca/metabolismo , Proteínas Associadas à Resistência a Múltiplos Medicamentos/biossíntese , Miocárdio/metabolismo , Choque Séptico/metabolismo , Animais , Células Cultivadas , Colo , Modelos Animais de Doenças , Endotélio/metabolismo , Endotélio/patologia , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Insuficiência Cardíaca/induzido quimicamente , Insuficiência Cardíaca/patologia , Interleucina-6/sangue , Interleucina-6/farmacologia , Lipopolissacarídeos/toxicidade , Camundongos , Miocárdio/patologia , Miócitos Cardíacos/metabolismo , Miócitos Cardíacos/patologia , Miócitos de Músculo Liso/metabolismo , Miócitos de Músculo Liso/patologia , Óxido Nítrico/metabolismo , Peritonite/metabolismo , Peritonite/patologia , Reação em Cadeia da Polimerase , RNA Mensageiro , Choque Séptico/induzido quimicamente , Choque Séptico/patologia , Stents
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA